We are live on ! Find out more

ADMA Biologics

ADMA

Market cap $2.63B

11.75 USD

+0.47

4.17%

At close Updated Oct 29, 4:00 PM EDT

Pre-market

After hours

11.70

-0.05

0.43%

1 day

4.17%

5 days

8%

1 month

17.97%

3 months

34.9%

6 months

10.85%

Year to date

-34.28%

1 year

-24.34%

5 years

810.85%

10 years

110.57%

About: ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Employees: 647

Healthcare Biotechnology

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 6.5%

Neutral 89.7%

Negative 3.7%

Zacks Investment Research

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet

Zacks Investment Research

Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know

Adma Biologics (ADMA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Investors Heavily Search ADMA Biologics Inc (ADMA): Here is What You Need to Know

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

RAMSEY, N.J. and BOCA RATON, Fla.

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

Zacks Investment Research

Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing

Adma Biologics (ADMA) closed the most recent trading day at $11.24, moving +1.49% from the previous trading session.

Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Optimized Process Demonstrated Effective Removal of Procoagulant Impurities While Maintaining Immunoglobulin Quality and Increasing IgG Yield

ADMA Biologics Announces Peer-Reviewed Publication Highlighting New Data From Its Optimized, Proprietary IVIG Manufacturing Process

Zacks Investment Research

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?

Zacks Investment Research

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

In the latest trading session, Adma Biologics (ADMA) closed at $10.33, marking a +1.87% move from the previous day.

Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors

Zacks Investment Research

ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Adma Biologics (ADMA). This makes it worthwhile to examine what the stock has in store.

ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

In the most recent trading session, Adma Biologics (ADMA) closed at $10, indicating a -1.24% shift from the previous trading day.

Here's Why Adma Biologics (ADMA) Fell More Than Broader Market

Zacks Investment Research

Why Adma Biologics (ADMA) Dipped More Than Broader Market Today

Adma Biologics (ADMA) closed at $9.52 in the latest trading session, marking a -1.86% move from the prior day.

Why Adma Biologics (ADMA) Dipped More Than Broader Market Today

See News Rankings

Price charts implemented using Lightweight Charts™